JPMorgan Chase & Co. Has $230,000 Holdings in Capricor Therapeutics Inc (NASDAQ:CAPR)
JPMorgan Chase & Co. trimmed its position in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) by 70.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,680 shares of the biotechnology company’s stock after selling 39,519 shares during the period. […]
JPMorgan Chase & Co. trimmed its position in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) by 70.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,680 shares of the biotechnology company’s stock after selling 39,519 shares during the period. […]
